John Fesko, President and Chief Business Officer of Natera, Inc. (NASDAQ:), a $22.1 billion market cap company that has delivered an impressive 159% return over the past year according to InvestingPro, recently sold shares of the company’s stock valued at approximately $3.5 million, according to a recent SEC filing. The transactions, which occurred on January 22, involved the sale of 21,228 shares at prices ranging from $164.9488 to $171.9617 per share. Following these sales, Fesko retains ownership of 147,230 shares in the medical laboratory services company. The sales were made to satisfy tax withholding obligations related to the vesting of restricted stock units. The company has shown strong momentum with a 64% price gain over the past six months, and maintains a GOOD overall financial health rating. For comprehensive insider trading analysis and 11 additional key ProTips, visit InvestingPro.
In other recent news, genetic…
